\uff5e \u753b\u671f\u7684\u306a\u304c\u3093\u6cbb\u7642\u85ac\u3084\u30b9\u30da\u30b7\u30e3\u30ea\u30c6\u30a3\u30c9\u30e9\u30c3\u30b0\u306b\u3088\u308b\u3001<\/p>\n
\u30b3\u30de\u30fc\u30b7\u30e3\u30eb\u30e2\u30c7\u30eb\u306e\u5909\u9769\u3084\u60a3\u8005\u306e\u751f\u6d3b\u5411\u4e0a\u306e\u8ca2\u732e\u306b\u3064\u3044\u3066\u3001<\/p>\n
Alnylam\u793e\u3068Pfizer\u793e\u306e\u30a8\u30b0\u30bc\u30af\u30c6\u30a3\u30d6\u304c\u30c7\u30a3\u30b9\u30ab\u30c3\u30b7\u30e7\u30f3<\/p>\n
<\/p>\n
\u696d\u754c\u3092\u727d\u5f15\u3059\u308b\u4f01\u696d\u304c\u30ab\u30b9\u30bf\u30de\u30fc\u30a8\u30f3\u30b2\u30fc\u30b8\u30e1\u30f3\u30c8\u3092\u63a8\u9032\u3059\u308b<\/p>\n
\u30c7\u30b8\u30bf\u30eb\u30c8\u30e9\u30f3\u30b9\u30d5\u30a9\u30fc\u30e1\u30fc\u30b7\u30e7\u30f3\u30a4\u30cb\u30b7\u30a2\u30c6\u30a3\u30d6\u306e\u53d6\u308a\u7d44\u307f\u3092\u7d39\u4ecb \uff5e<\/p>\n
<\/p>\n
2020\u5e745\u670829\u65e5<\/p>\n
³Ô¹Ï±¬ÁÏ Japan\u682a\u5f0f\u4f1a\u793e<\/p>\n
<\/p>\n
³Ô¹Ï±¬ÁÏ Systems\u3010NYSE:VEEV\u3011(\u672c\u793e : \u30ab\u30ea\u30d5\u30a9\u30eb\u30cb\u30a2\u5dde\u30d7\u30ec\u30b6\u30f3\u30c8\u30f3\u3001\u65e5\u672c\u6cd5\u4eba \u672c\u793e : \u6771\u4eac\u90fd\u6e0b\u8c37\u533a\u3001\u65e5\u672c\u6cd5\u4eba\u4ee3\u8868\u53d6\u7de0\u5f79 : \u5ca1\u6751 \u5d07\u3001\u4ee5\u4e0b ³Ô¹Ï±¬ÁÏ) \u306f\u3001Alnylam Pharmaceuticals\u793e\u30d7\u30ec\u30b8\u30c7\u30f3\u30c8\u306eBarry Greene\u6c0f\u3068Pfizer\u793e\u30b0\u30ed\u30fc\u30d0\u30eb\u30d7\u30ec\u30b8\u30c7\u30f3\u30c8\u517c\u30aa\u30f3\u30b3\u30ed\u30b8\u30fc\u62c5\u5f53\u30bc\u30cd\u30e9\u30eb\u30de\u30cd\u30fc\u30b8\u30e3\u30fc\u306eAndy Schmeltz\u6c0f\u304c\u30012020 ³Ô¹Ï±¬ÁÏ Commercial & Medical Summit Online<\/a><\/strong>\u306b\u57fa\u8abf\u8b1b\u6f14\u8005\u3068\u3057\u3066\u767b\u58c7\u3059\u308b\u3053\u3068\u3092\u767a\u8868\u3057\u307e\u3057\u305f\u3002Alnylam\u793e\u3068Pfizer\u793e\u306f\u3001\u304c\u3093\u6cbb\u7642\u85ac\u3068\u30b9\u30da\u30b7\u30e3\u30ea\u30c6\u30a3\u30c9\u30e9\u30c3\u30b0\u306b\u304a\u3051\u308b\u30d6\u30ec\u30fc\u30af\u30b9\u30eb\u30fc\u3067\u3001\u30e9\u30a4\u30d5\u30b5\u30a4\u30a8\u30f3\u30b9\u696d\u754c\u3068\u793e\u4f1a\u306b\u5909\u9769\u3092\u3082\u305f\u3089\u3059\u79d1\u5b66\u7684\u767a\u898b\u306e\u6700\u5148\u7aef\u3067\u696d\u754c\u3092\u30ea\u30fc\u30c9\u3057\u3066\u3044\u307e\u3059\u3002(\u672c\u30ea\u30ea\u30fc\u30b9\u306f\u3001³Ô¹Ï±¬ÁÏ\u7c73\u56fd\u672c\u793e\u304c\u767a\u8868\u3057\u305f\u5831\u9053\u8cc7\u6599\u306e\u6284\u8a33\u3067\u3059\u3002\u539f\u6587\u306f\u3053\u3061\u3089<\/a><\/strong>\u304b\u3089\u304a\u8aad\u307f\u3044\u305f\u3060\u3051\u307e\u3059\u3002)<\/p>\n <\/p>\n Alnylam\u793e\u306f\u3001RNAi\u6cbb\u7642\u85ac\u3068\u547c\u3070\u308c\u308b\u65b0\u305f\u306a\u30af\u30e9\u30b9\u306e\u533b\u85ac\u54c1\u3092\u958b\u767a\u3057\u30012018\u5e74\u306bRNAi\u6cbb\u7642\u85ac\u3067\u306f\u521d\u306e\u7c73\u56fd\u98df\u54c1\u533b\u85ac\u54c1\u5c40\uff08FDA\uff09\u306e\u627f\u8a8d\u3092\u5f97\u307e\u3057\u305f\u3002Pfizer\u793e\u306e\u30aa\u30f3\u30b3\u30ed\u30b8\u30fc\u90e8\u9580\u306f\u3001\u3053\u306e10\u5e74\u9593\u3067\u30dd\u30fc\u30c8\u30d5\u30a9\u30ea\u30aa\u3092\u5927\u5e45\u306b\u62e1\u5145\u3057\u3001\u304c\u3093\u3068\u5171\u751f\u3059\u308b\u4eba\u3005\u306b\u79d1\u5b66\u7814\u7a76\u306b\u57fa\u3065\u3044\u305f\u6709\u52b9\u306a\u533b\u85ac\u54c1\u3092\u63d0\u4f9b\u3059\u308b\u305f\u3081\u306b\u5927\u80c6\u306a\u53d6\u308a\u7d44\u307f\u3092\u884c\u3063\u3066\u3044\u307e\u3059\u3002<\/p>\n \u30d1\u30cd\u30eb\u30c7\u30a3\u30b9\u30ab\u30c3\u30b7\u30e7\u30f3\u306b\u306fGreene\u6c0f\u3068Schmeltz\u6c0f\u304c\u53c2\u52a0\u3057\u3001\u79d1\u5b66\u306e\u6025\u901f\u306a\u767a\u5c55\u3084\u60a3\u8005\u4e2d\u5fc3\u306e\u533b\u7642\u306b\u5411\u3051\u305f\u696d\u754c\u306e\u52d5\u5411\u306b\u3088\u3063\u3066\u63a8\u9032\u3055\u308c\u308b\u3001\u30b3\u30de\u30fc\u30b7\u30e3\u30eb\u30e2\u30c7\u30eb\u3084\u533b\u7642\u5236\u5ea6\u306e\u9032\u5316\u306b\u3064\u3044\u3066\u5c55\u671b\u3092\u304a\u8a71\u3057\u3044\u305f\u3060\u304d\u307e\u3059\u3002<\/p>\n 2020 ³Ô¹Ï±¬ÁÏ Summit Online\u306f6\u67089\uff5e10\u65e5\u306b\u958b\u50ac\u3055\u308c\u300160\u3092\u8d85\u3048\u308b\u30e9\u30a4\u30d6\u304a\u3088\u3073\u30aa\u30f3\u30c7\u30de\u30f3\u30c9\u30bb\u30c3\u30b7\u30e7\u30f3\u304c\u4e88\u5b9a\u3055\u308c\u3066\u3044\u307e\u3059\u3002\u4e16\u754c\u3092\u30ea\u30fc\u30c9\u3059\u308b\u88fd\u85ac\u4f01\u696d\u3084\u30d0\u30a4\u30aa\u30c6\u30af\u30ce\u30ed\u30b8\u30fc\u4f01\u696d\u304b\u3089\u8b1b\u6f14\u8005\u3092\u62db\u304d\u3001\u60a3\u8005\u306b\u533b\u7642\u3092\u63d0\u4f9b\u3059\u308b\u533b\u5e2b\u3084\u533b\u7642\u6a5f\u95a2\u3068\u306e\u9023\u643a\u5f37\u5316\u3092\u53ef\u80fd\u306b\u3057\u3066\u3044\u308b\u3001\u65b0\u3057\u3044\u30c7\u30b8\u30bf\u30eb\u30a8\u30f3\u30b2\u30fc\u30b8\u30e1\u30f3\u30c8\u30e2\u30c7\u30eb\u3078\u3068\u6025\u901f\u306b\u30b7\u30d5\u30c8\u3057\u3066\u3044\u308b\u72b6\u6cc1\u306b\u3064\u3044\u3066\u8a9e\u3063\u3066\u3044\u305f\u3060\u304d\u307e\u3059\u3002\u3055\u3089\u306b\u4eca\u56de\u521d\u3081\u3066\u3001\u30d6\u30e9\u30f3\u30c9\u30de\u30fc\u30b1\u30bf\u30fc\u304c\u30c7\u30b8\u30bf\u30eb\u30de\u30fc\u30b1\u30c6\u30a3\u30f3\u30b0\u3084\u30d7\u30e9\u30a4\u30d0\u30b7\u30fc\u3001\u60a3\u8005\u30a2\u30ca\u30ea\u30c6\u30a3\u30af\u30b9\u306b\u95a2\u3059\u308b\u30d9\u30b9\u30c8\u30d7\u30e9\u30af\u30c6\u30a3\u30b9\u3092\u5b66\u7fd2\u3057\u3066\u5171\u6709\u3059\u308b\u305f\u3081\u306e\u30c8\u30e9\u30c3\u30af\u3082\u4e88\u5b9a\u3057\u3066\u3044\u307e\u3059\u3002<\/p>\n Alnylam\u793e\u3001Antares Pharma\u793e\u3001AstraZeneca\u793e\u3001Bayer\u793e\u3001Biogen\u793e\u3001Biohaven Pharmaceuticals\u793e\u3001Boehringer Ingelheim\u793e\u3001Bristol Myers Squibb\u793e\u3001EMD Serono\u793e\u3001Flexion Therapeutics\u793e\u3001Galderma\u793e\u3001GSK\u793e\u3001Immunomedics\u793e\u3001Mallinckrodt Pharmaceuticals\u793e\u3001Merck\u793e\u3001Novartis\u793e\u3001Novo Nordisk\u793e\u3001Otsuka Pharmaceutical Companies\u793e\uff08\u7c73\u56fd\uff09\u3001Paratek Pharmaceuticals\u793e\u3001Pfizer\u793e\u3001Roche\u793e\u3001Sanofi\u793e\u3001Strongbridge Biopharma\u793e\u3001Taiho Oncology\u793e\u3001Upsher-Smith Laboratories\u793e\u306a\u3069\u300125\u793e\u3092\u8d85\u3048\u308b\u4f01\u696d\u304b\u3089\u30b3\u30de\u30fc\u30b7\u30e3\u30eb\u90e8\u9580\u306e\u30ea\u30fc\u30c0\u30fc\u304c\u8b1b\u6f14\u3092\u884c\u3046\u4e88\u5b9a\u3067\u3059\u3002<\/p>\n \u4eca\u5e74\u306e\u30a4\u30d9\u30f3\u30c8\u306f\u3001\u696d\u754c\u3092\u727d\u5f15\u3059\u308b\u30b5\u30fc\u30d3\u30b9\u3001\u30c6\u30af\u30ce\u30ed\u30b8\u30fc\u3001\u304a\u3088\u3073\u30b3\u30f3\u30c6\u30f3\u30c4\u30d1\u30fc\u30c8\u30ca\u30fc\u3067\u3042\u308b40\u793e\u304c\u30b9\u30dd\u30f3\u30b5\u30fc\u3067\u3059\u3002\u30d7\u30e9\u30c1\u30ca\u30b9\u30dd\u30f3\u30b5\u30fc\u306fAktana\u793e\u3001Deloitte\u793e\u3001Qlik\u793e\u3001Salesforce\u793e\u3001\u304a\u3088\u3073ZS Associates\u793e\u3067\u3059\u3002\u30b4\u30fc\u30eb\u30c9\u30b9\u30dd\u30f3\u30b5\u30fc\u306fConexus Solutions\u793e\u3001Framework Solutions\u793e\u3001HealthSTAR Strategic Engagements\u793e\u3001Knipper\u793e\u3001LPW Training Services\u793e\u3001Mavens\u793e\u3001NAVOMI\u793e\u3001OwnBackup\u793e\u3001\u304a\u3088\u3073Viseven\u793e\u3067\u3059\u3002<\/p>\n ³Ô¹Ï±¬ÁÏ Summit Online\u306f\u30e9\u30a4\u30d5\u30b5\u30a4\u30a8\u30f3\u30b9\u696d\u754c\u95a2\u4fc2\u8005\u9650\u5b9a\u306e\u30a4\u30d9\u30f3\u30c8\u3067\u3059\u3002\u53c2\u52a0\u767b\u9332\u304a\u3088\u3073\u8a73\u7d30\u306b\u3064\u3044\u3066\u306fveeva.com\/jp\/Summit<\/a><\/strong>\u3092\u3054\u89a7\u304f\u3060\u3055\u3044\u3002<\/p>\n <\/p>\n \u3010<\/strong>³Ô¹Ï±¬ÁÏ Systems<\/strong>\u793e\u306b\u3064\u3044\u3066\u3011<\/strong> \u3010Forward-looking Statements\u3011 Alnylam\u793e\u3068Pfizer\u793e\u306e\u30a8\u30b0\u30bc\u30af\u30c6\u30a3\u30d6\u304c\u30d1\u30cd\u30eb\u30c7\u30a3\u30b9\u30ab\u30c3\u30b7\u30e7\u30f3\u306b\u3082\u53c2\u52a0<\/p>\n","protected":false},"author":131,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[322,341],"tags":[],"class_list":["post-43610","post","type-post","status-publish","format-standard","hentry","category-press-release","category-case-study"],"acf":[],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/posts\/43610"}],"collection":[{"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/users\/131"}],"replies":[{"embeddable":true,"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/comments?post=43610"}],"version-history":[{"count":6,"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/posts\/43610\/revisions"}],"predecessor-version":[{"id":50436,"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/posts\/43610\/revisions\/50436"}],"wp:attachment":[{"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/media?parent=43610"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/categories?post=43610"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/tags?post=43610"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}
\n³Ô¹Ï±¬ÁÏ Systems\u793e\u306f\u30b0\u30ed\u30fc\u30d0\u30eb\u306a\u30e9\u30a4\u30d5\u30b5\u30a4\u30a8\u30f3\u30b9\u4f01\u696d\u5411\u3051\u306b\u30af\u30e9\u30a6\u30c9\u30d9\u30fc\u30b9\u306e\u30bd\u30d5\u30c8\u30a6\u30a7\u30a2\u3092\u63d0\u4f9b\u3059\u308b\u30ea\u30fc\u30c7\u30a3\u30f3\u30b0\u30ab\u30f3\u30d1\u30cb\u30fc\u3067\u3059\u3002\u4e16\u754c\u6700\u5927\u898f\u6a21\u306e\u88fd\u85ac\u4f1a\u793e\u304b\u3089\u30d0\u30a4\u30aa\u30c6\u30af\u30ce\u30ed\u30b8\u30fc\u5206\u91ce\u306e\u65b0\u8208\u4f01\u696d\u307e\u3067\u3001850\u793e\u3092\u8d85\u3048\u308b\u9867\u5ba2\u306b\u6280\u8853\u9769\u65b0\u3078\u306e\u53d6\u308a\u7d44\u307f\u3084\u5353\u8d8a\u3057\u305f\u88fd\u54c1\u529b\u306b\u3088\u3063\u3066\u3001\u304a\u5ba2\u69d8\u306e\u6210\u529f\u306b\u30b3\u30df\u30c3\u30c8\u3059\u308b\u69d8\u3005\u306a\u30b5\u30fc\u30d3\u30b9\u3092\u63d0\u4f9b\u3057\u3066\u3044\u307e\u3059\u3002³Ô¹Ï±¬ÁÏ\u306f\u3001\u30b5\u30f3\u30d5\u30e9\u30f3\u30b7\u30b9\u30b3\u306e\u30d9\u30a4\u30a8\u30ea\u30a2\u306b\u672c\u793e\u3092\u7f6e\u304d\u3001\u30e8\u30fc\u30ed\u30c3\u30d1\u3001\u30a2\u30b8\u30a2\u3001\u30e9\u30c6\u30f3\u30a2\u30e1\u30ea\u30ab\u306b\u62e0\u70b9\u3092\u5c55\u958b\u3057\u3066\u3044\u307e\u3059\u3002\u8a73\u3057\u304f\u306f\u3001https:\/\/veeva.com\/jp\/<\/a>\u3092\u3054\u89a7\u304f\u3060\u3055\u3044\u3002<\/p>\n
\nThis release contains forward-looking statements, including the market demand for and acceptance of ³Ô¹Ï±¬ÁÏ\u2019s products and services, the results from use of ³Ô¹Ï±¬ÁÏ\u2019s products and services, and general business conditions, particularly in the life sciences industry. Any forward-looking statements contained in this press release are based upon ³Ô¹Ï±¬ÁÏ\u2019s historical performance and its current plans, estimates, and expectations, and are not a representation that such plans, estimates, or expectations will be achieved. These forward-looking statements represent ³Ô¹Ï±¬ÁÏ\u2019s expectations as of the date of this press announcement. Subsequent events may cause these expectations to change, and ³Ô¹Ï±¬ÁÏ disclaims any obligation to update the forward-looking statements in the future. These forward-looking statements are subject to known and unknown risks and uncertainties that may cause actual results to differ materially. Additional risks and uncertainties that could affect ³Ô¹Ï±¬ÁÏ\u2019s financial results are included under the captions, \u201cRisk Factors\u201d and \u201cManagement\u2019s Discussion and Analysis of Financial Condition and Results of Operations,\u201d in the company\u2019s filing on F Form 10-K for the period ended January\u00a031, 2020. This is available on the company\u2019s website at www.veeva.com<\/a> under the Investors section and on the SEC\u2019s website at www.sec.gov<\/a>. Further information on potential risks that could affect actual results will be included in other filings ³Ô¹Ï±¬ÁÏ makes with the SEC from time to time.<\/p>\n","protected":false},"excerpt":{"rendered":"